Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP801997.RAVgExrq2P8b-3eqdR2aBWYxSn2E4n3IglE7eG-dbErq8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801997.RAVgExrq2P8b-3eqdR2aBWYxSn2E4n3IglE7eG-dbErq8130_assertion type Assertion NP801997.RAVgExrq2P8b-3eqdR2aBWYxSn2E4n3IglE7eG-dbErq8130_head.
- NP801997.RAVgExrq2P8b-3eqdR2aBWYxSn2E4n3IglE7eG-dbErq8130_assertion description "[We observed that the positive expression of LC3 and Beclin 1 was significantly higher in the samples of benign and borderline ovarian tumors than those in malignant epithelial ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801997.RAVgExrq2P8b-3eqdR2aBWYxSn2E4n3IglE7eG-dbErq8130_provenance.
- NP801997.RAVgExrq2P8b-3eqdR2aBWYxSn2E4n3IglE7eG-dbErq8130_assertion evidence source_evidence_literature NP801997.RAVgExrq2P8b-3eqdR2aBWYxSn2E4n3IglE7eG-dbErq8130_provenance.
- NP801997.RAVgExrq2P8b-3eqdR2aBWYxSn2E4n3IglE7eG-dbErq8130_assertion SIO_000772 18776739 NP801997.RAVgExrq2P8b-3eqdR2aBWYxSn2E4n3IglE7eG-dbErq8130_provenance.
- NP801997.RAVgExrq2P8b-3eqdR2aBWYxSn2E4n3IglE7eG-dbErq8130_assertion wasDerivedFrom befree-20150227 NP801997.RAVgExrq2P8b-3eqdR2aBWYxSn2E4n3IglE7eG-dbErq8130_provenance.
- NP801997.RAVgExrq2P8b-3eqdR2aBWYxSn2E4n3IglE7eG-dbErq8130_assertion wasGeneratedBy ECO_0000203 NP801997.RAVgExrq2P8b-3eqdR2aBWYxSn2E4n3IglE7eG-dbErq8130_provenance.